Dr. Jonathan Rosenberg says the expanded approval of enfortumab vedotin as a therapy for muscle-invasive urothelial carcinoma “feels like a huge sea change in how we treat patients, and hopefully a ...

Sir Chris Hoy’s stage-four diagnosis has put prostate cancer under the spotlight among cyclists. Cycling Weekly tackles the ...